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Has working-age morbidity been declining? Changes over time in 
general health, chronic diseases, symptoms and biomarkers in 
England 1994-2014 
Abstract: 
Objectives: As life expectancy has increased in high-income countries, there has been a global 
debate about whether additional years of life are free from ill-health/disability. However, 
little attention has been given to changes over time in morbidity in the working-age 
population, particularly outside the US, despite its importance for health monitoring and 
social policy. This study therefore asks: what are the changes over time in working-age 
morbidity in England over two decades? 
Design, setting and participants: We use a high-quality annual cross-sectional survey, the 
Health Survey for England (‘HSE’) 1994-2014. HSE uses a random sample of the English 
household population, with a combined sample size of over 140,000 people. We produce a 
newly-harmonised version of HSE that maximises comparability over time, including new 
non-response weights. While HSE is used for monitoring population health, it has hitherto 
not used for investigating morbidity as a whole. 
Outcome measures: We analyse all 39 measures that are fully comparable over time – 
including chronic disease diagnoses, symptomatology and a number of biomarkers – 
adjusting for gender and age.  
Results: We find a mixed picture: we see improving cardiovascular and respiratory health, 
but deteriorations in obesity, diabetes, some biomarkers, and feelings of extreme 
anxiety/depression, alongside stability in moderate mental ill-health and musculoskeletal-
related health. In several domains we also see stable or rising chronic disease diagnoses even 
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where symptomatology has declined. While data limitations make it challenging to combine 
these measures into a single morbidity index, there is little systematic trend for declining 
morbidity to be seen in the measures that predict self-reported health most strongly. 
Conclusions: Despite considerable falls in working-age mortality – and the assumptions of 
many policymakers that morbidity will follow mortality – there is no systematic 
improvement in overall working-age morbidity in England from 1994 to 2014. 
Strengths and limitations of this study 
 We provide a robust analysis of changes over time in morbidity in England for 39 
measures across two decades using the Health Survey for England (‘HSE’). 
 We include every morbidity measure for which consistent comparisons over time 
can be constructed in the HSE.  
 We take care to maximise comparability over time, including constructing new non-
response weights.  
 However, response rates for each stage of the HSE have declined over time, and it is 
impossible to rule out changing non-response biases.  





As life expectancy has increased in high-income countries, there has been a global debate 
about whether additional years of life are free from ill-health/disability. It is now largely 
accepted that old-age disability has declined in the US (albeit varying by age/method),1 2 
although chronic illness increased,3 and the picture beyond the US is more mixed.4-6 Yet this 
research agenda has not been matched by similar attention to changes over time in 
morbidity in the working-age population. In the absence of direct evidence, policymakers 
have often made claims based on self-reports of general health,6-8 which we know are 
unreliable.9 10 The lack of evidence is even more problematic within social security, where 
many policymakers have assumed that working-age morbidity must have improved in recent 
decades given improvements in mortality (despite the potential for declining mortality to 
coexist with rising morbidity)6 – and that therefore high/rising levels of claims are not 
‘genuine’.11 12  
Almost the only direct evidence on changes over time in working-age morbidity in high-
income countries comes from the US. Contrary to policymaker expectations, these studies 
have generally found deteriorating morbidity since the mid-1990s, particularly activities of 
daily living (ADLs) and physical functioning.13-16 Other studies have focused on the older 
working-age population with similar results.2 17 Again, not all measures show deteriorations, 
and not all studies come to identical conclusions,18 but there is little sign of any 
improvement in morbidity among working-age Americans – despite a 23% fall in working-
age mortality 1993-2013 (Web Appendix 1). Outside of the US, there is a paucity of 




This study therefore asks: is there empirical support for the hypothesis that working-age 
morbidity in England has declined? (H1). Or does the evidence support alternative 
hypotheses of stable (H2) or even declining (H3) morbidity? We answer this using the 
Health Survey for England (HSE), a high quality Government survey with a combined sample 
of 140,000 individuals. We examine 39 specific aspects of morbidity rather than reducing 
morbidity to a single measure, partly because these produce more reliable trends, and partly 
to capture the multidimensional nature of morbidity.23 However, we conclude by examining 
the broad picture of morbidity change, and how far this supports the competing hypotheses.  
This analysis makes two contributions. Firstly, we provide one of the few systematic 
analyses of changes over time in working-age morbidity in any high-income country outside 
the US. Secondly, we supplement self-report measures with 10 ‘biomarkers’, which are 
particularly valuable for showing genuine changes over time (rather than merely changes in 
how people describe their health), but which have rarely been examined alongside self-
reported working-age morbidity trends (Martin et al. 201024 being an exception).  
DATA AND METHODS 
This section follows the STROBE cross sectional reporting guidelines.25  
Data source 
Robust evidence of change over time requires consistently-collected, high-quality data. We 
use the HSE, an annual government-sponsored cross-sectional survey of 3,000-11,000 adults 
with no proxy responses.26-47 A particular advantage is that the interview is followed by a 
nurse visit, which in selected years also includes a blood sample. Nevertheless, there are 
challenges in analysing change in HSE:  
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 Firstly, HSE was run by the Government Office of Population Censuses and Surveys 
in 1991-3, before changing to NatCen  in 1994. We focus on 1994-2014 given 
evidence of a discontinuity at this point. 
 Secondly, topic coverage of HSE varies year-to-year, accompanied by changes in 
question wording/filtering. Based on a systematic search of HSE questions, we have 
included every morbidity measure that is comparable over a significant duration. 
Even for measures that have been previously been analysed (e.g. BMI48), this new 
analysis uncovered further discontinuities (Web Appendices 2 & 3). 
 Third, HSE excludes those in communal establishments. While a smaller problem for 
the working-age population than older ages,2 we minimise the impact of rising 
university attendance by focussing on those aged 25+ (Web Appendix 3). The upper 
limit of the working-age population is set to 59 (women) and 64 (men) to match 
state pension ages at the start of the period.  
 Fourth, HSE supplies non-response weights from 2003. However, there had been a 
substantial decline in response rates prior to the introduction of weights, particularly 
for blood samples (from 53.3% 1994 to 39.9% 2003; Web Appendix 3). We 
therefore reduce non-response biases by creating new non-response weights, 
described in Web Appendix 3. 
The resulting sample sizes for the various stages of data collection are shown in Web 
Appendix 3. Our dataset substantially extends an existing HSE time-series dataset (UK Data 
Archive SN7025); the code enabling other researchers to assemble this extended time-




As this is a health monitoring study using secondary data, patients were not directly 
involved. However, from previous discussions we are aware that the study will be of 
interest to patient/disability advocacy groups, who will receive jargon-free summaries of the 
research. 
Measures 
We cannot interpret changes over time correctly without understanding different ways of 
operationalising ‘morbidity’.1 General health/disability measures – e.g. “How is your health in 
general?” – are a simple way of measuring morbidity with a single indicator, and clearly do 
capture something meaningful.50 However, their generality means that despite consistent 
question wording, different people may interpret questions or response options differently 
(e.g. what ‘good’ health refers to).51 p218-224 This can even occur within individuals, if they 
change their internal standards of measurement over time (contributing to ‘response 
shift’52). Numerous causal factors contribute to variable comprehension/reporting, ranging 
from the experience of ill-health itself52 to non-health factors such as social security 
incentives,53 gendered- and age-related expectations, and medicalisation.54  
These inconsistencies mean that general health/disability measures are inadequate for 
answering our question: trends in such measures can differ wildly between different surveys 
covering nominally the same concept and population, e.g. for disability in England9 or self-
rated health in the US.10 Indeed, the HSE itself shows that England has experienced 
deteriorating ‘bad general health’ at the same time as activity limitations have fallen (changes 
over time in seven general HSE health/disability measures are available in Web Appendix 4). 
Moreover, single indicator measures are potentially misleading in that they gloss over the 
multidimensional nature of morbidity.1 
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To robustly answer our research question, we must instead focus on more specific 
morbidity measures that capture multiple aspects of morbidity. Our systematic search found 
39 such measures that are comparable over time: these are summarised in Table 1, with 
further details in Web Appendix 5. (A further 29 measures are also included in Web 
Appendix 6; this includes 8 sub-components of measures in the main text, 16 reports of 
ever having a condition even if this not recent, and 5 other categories of LSI). These specific 
morbidity measures can be grouped into three types, which have different strengths and 
weaknesses with respect to our question: 
1. Medical labels: some measures are based on medical labels, either diagnosed chronic 
diseases or self-reported types of longstanding illness. (Those reporting a 
longstanding illness were asked, ‘what is the matter with you?’; up to 6 responses were 
then coded by the interviewer based on ICD). These are imperfect measures of 
morbidity55 as they partly reflect healthcare systems and medicalisation more 
broadly, both of which change over time. Nevertheless, they are an important 
element of morbidity as they have real consequences via increasing 
awareness/labelling of people’s experiences.   
2. Symptom-based: some measures are based on self-reports of ill-health symptoms or 
specific domains of activity limitations. These measures are either single items (e.g. 
pain, anxiety/depression) or validated symptom scales (e.g. the Rose angina scale,56 57   
GHQ psychiatric distress58). The more specific and concrete nature of these 
measures prima facie makes more likely to be interpreted consistently over time than 
medical labels and general measures,. Others have reached a similar conclusion for 
comparisons across place,55 particularly for disability measurement,59 60 where the 
Washington Group on Disability Statistics – a UN agency founded in 2001 – have 
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brokered a consensus that cross-country disability comparisons should be based on 
multiple measures of specific activity limitations.61 62 We should nevertheless note 
that there is no guarantee that a given symptom/impairment-based question will be 
interpreted identically over time.63 64  
3. Biomarkers – that is, objective measures of biological or physiological measures – 
have considerable strengths in analysing change, as they largely avoiding reporting 
biases that are likely to vary between socioeconomic groups and over time.65 They 
do this at the price of an indirect and sometimes still-debated relationship to 
morbidity (see Web Appendix 5), and do not cover several important morbidity 
domains (e.g. we lack good biomarkers for mental distress, pain and fatigue). 
 
These three types of measures are therefore complementary in understanding changing 
morbidity: biomarkers are least likely to be affected by changing respondent interpretations 
over time, but do not capture morbidity well; symptom-based measures capture morbidity 
well and are reasonably (if still imperfectly) reliable; and label-based measures are flawed in 
capturing symptoms/limitations but do enable us to capture whether people consider 
themselves to have a medical condition.  
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Table 1: HSE morbidity measures 
Category Measure Typea Operationalisation (years available) 
Cardio- High blood pressure LSIb L Hypertension reported as longstanding illness (LSI) (1994-2011) 
vascular Recent high blood pressure L Still has (or on medication for) doctor-diagnosed hypertension (1994-2013) 
disease (CVD) Biomarker high blood pressure B Systolic BP >=140mmHg & diastolic BP >=90mmHg (1994-2013) 
 High total cholesterol B Total cholesterol >= 5mmol/L (1994-2012) 
 Low HDL cholesterol B High density lipoprotein (HDL) cholesterol <=1 mmol/L (1998-2013) 
 Recent heart attack /stroke L Doctor-diagnosed heart attack or stroke in past 12mths (1994-2011) 
 Recent angina L Doctor-diagnosed angina in past 12mths (1994-2011) 
 Ischaemic heart/stroke LSIb L Stroke, heart attack or angina reported as longstanding illness (LSI) (1994-2011) 
 Heart attack symptoms S Ever had severe pain across chest for ½hr (1994-2011) 
 Mini stroke (TIA) symptoms S Attack of weakness/slurred speech/blurred vision in past 12mths (2003-11) 
 Angina symptoms S Rose Angina scale definition of angina symptoms (1994-2011) 
 Any recent CVD L Doctor-diagnosed heart condition (exc. hypertension) in past 12mths (1994-2011) 
 Any CVD LSI L Any CVD reported as longstanding illness (LSI) (1994-2011) 
Respiratory COPD symptoms  S Regular cough & phlegm for at least 3mths each year (1995-2010) 
 Lifetime diagnosed asthma L Ever had doctor-diagnosed asthma (1995-2010) 
 Asthma LSIb L Asthma reported as longstanding illness (LSI) (1994-2011) 
 Breathlessness-grade 2 S Short of breath when hurrying up walking uphill (1995-2010) 
 Breathlessness-grade 3 S Short of breath when walking on level ground (1995-2010) 
 Recent wheezing/asthma S Wheezing, whistling in chest or asthma attack in past 12mths (1995-2010) 
 Wheezing stopping sleep S Woken 1+ times/wk by wheezing/whistling in chest in last 12mths (1994-2010) 
Obesity BMI-underweight B Body Mass Index (BMI) <=18.5kg/m2 (1994-2013) 
& diabetes BMI-obese B Body Mass Index (BMI) >= 30kg/m2   (1994-2013) 
 High waist-hip ratio B Waist-hip ratio of >1 for men and >0.85 for women (1994-2013) 
 Recent diabetes L Currently taking medication for doctor-diagnosed diabetes (1994-2013) 
 Diabetes LSIb L Diabetes reported as longstanding illness (LSI) (1994-2011) 
 High glycated haemoglobin B HbA1C >=48mmol/mol (2003-2013) 
Mental  Mental health LSIb L Mental health reported as longstanding illness (LSI) (1994-2011) 
Health Psychiatric distress (GHQ) S 4+ negative symptoms from 12-item General Health Questionnaire (1994-2014) 
 Anxiety/depression-moderately S At least moderately anxious/depressed today (1996-2014) 
 Anxiety/depression-extremely S Extremely anxious/depressed today (1996-2014) 
Activity  Problems walking today S Has at least some problems walking about today (1996-2014) 
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Category Measure Typea Operationalisation (years available) 
limitations Locomotor limitation S Can’t walk far / bend down / go up or down stairs without resting (1996-2001)  
& musculo- Problems washing/dressing today S Has at least some problems washing/dressing today (1996-2014) 
skeletal Self-care limitation S Difficulty with one of six everyday activities (e.g. feeding, dressing) (1995-2001) 
 Pain-any S Has at least some pain or discomfort today (1996-2014) 
 Pain-extreme S Has extreme pain or discomfort today (1996-2014) 
 Arthritis LSIb L Arthritis or rheumatism reported as longstanding illness (LSI) (1994-2011) 
 Other musculoskeletal LSIb L Other musculoskeletal condition reported as longstanding illness (LSI) (1994-2011) 
Sensory &  LSI Eye or Ear L Eye or ear condition reported as longstanding illness (LSI) (1994-2011) 
Communication Hearing limitation S Cannot follow TV programme at volume others find acceptable (1995-2001) 
 Seeing limitation S Cannot see well enough to recognise friend across the road (1995-2001) 
 Communicating limitation S Have problem communicating with other people (1995-2001) 
Other Raised C-reactive protein B CRP >3mg/L (1998-2009) 
Biomarkers Raised fibrinogen B Fibrinogen >4mg/L (1998-2009) 
 Anaemia B Haemoglobin <13g/dL for men and <12g/dL for women (1994-2009) 
 Iron deficiency B Serum ferritin < 45ng/ml (1994-2009) 
See Web Appendix 5 for full details on all measures .a Measure type key: L=medical label; S=symptom-based; B=biomarker. b Particular causes of longstanding illness (LSI) come 




In the first instance we look at unadjusted changes over time in each morbidity indicator, 
showing the actual levels of morbidity found in the population. However, we primarily focus 
on changes after adjustment for sex and age (following others66 67), akin to standardising for 
the age-sex composition of the population. Given that our aim is to describe changes rather 
than to explain them, we do not further adjust for potential causal influences on morbidity 
that are likely to vary over the period, such as employment over economic cycles. This is a 
task for future research, but we should note that such analysis is possible using our publicly-
available time-series dataset that includes inter alia employment status, education and region.  
We chose to examine discrete changes from the start to the end of available data for each 
measure, rather than using linear or non-linear trend terms. Given our aims of informing 
policy debates, this has three advantages: a discrete change is simple to interpret; it is 
compatible with the different start/end years available for different measures; and it does 
not require any assumptions about the functional form of trends (linear trends are 
particularly unlikely given the role of non-linear economic cycles). Individual survey years are 
grouped into 3-4 year periods to increase sample size and precision, but single-year 
prevalence is given in Web Appendix 7. Given our binary outcome measures, we use logistic 
regression models with the following form: 
 
…where  refers to a vector of period dummy variables (covering all periods in 
which there were any observations: 1994-96, 1997-2000, 2001-03, 2004-07, 2008-10 and 
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2011-14),  is a vector of our primary outcome coefficients showing change between each 
period and the earliest available period,  refers to a vector of age dummy variables, 
 refers to a binary gender dummy variable, and ,  and  refer to the coefficients 
on age, gender and their interaction respectively. We present average marginal effects 
rather than odds ratios, partly because these are simple to understand – odds ratios have no 
easy real-world interpretation for policymakers – but primarily because odds ratios are not 
fully comparable across different models, and cannot therefore underpin our comparison of 
changes over time between indicators.68 
To avoid a binary cut-off of statistical significance,69 95% confidence intervals are used to 
convey precision. All analyses use weights, exclude boost samples that use different sampling 
methods, and adjust for the multistage clustered sample design and the stratification of the 
sample across survey years using the SVYSET command in Stata (although standard errors 
will be slightly underestimated as it is not possible to consistently adjust for sample 
stratification within years). For reasons of space, we are unable to discuss previous HSE 
studies of aspects of morbidity in the main text; these are instead described in Web 
Appendix 8.  
RESULTS 
Conditions with sharply declining mortality 
We start by focussing on cardiovascular disease (CVD) and respiratory illness, which have 
both seen large falls in mortality (by >50% and >25% respectively among 0-64 year-olds 









Change from start to end period 
  Period 
 







Blood pressure/cholesterol       
High blood pressure LSIb 1994-96 2.7% 2011-14 1.3% 1.0% [0.4, 1.6%] 
Recent high blood pressure 1994-96 4.2% 2011-14 5.2% 4.8% [3.9, 5.6%] 
Biomarker high BP 1994-96 8.4% 2011-14 -4.7% -5.0% [-5.6, -4.5%] 
High total cholesterol 1994-96 75.7% 2011-14 -16.4% -17.6% [-19.1, -16.1%] 
Low HDL cholesterol 1997-2000 11.8% 2011-14 -8.0% -8.0% [-9.0, -7.1%] 
Other CVD       
Recent heart attack/stroke 1994-96 1.2% 2011-14 -0.3% -0.4% [-0.7, 0.0%] 
Recent angina 1994-96 1.1% 2011-14 -0.4% -0.5% [-0.8, -0.1%] 
IHD/stroke LSIb 1994-96 1.4% 2011-14 -0.4% -0.6% [-0.9, -0.2%] 
Heart attack symptoms 1994-96 5.5% 2011-14 -0.3% -0.5% [-1.3, 0.3%] 
Mini stroke (TIA) symptoms 2001-03 8.1% 2011-14 -1.4% -1.4% [-2.4, -0.4%] 
Angina symptoms 1994-96 2.3% 2011-14 -1.1% -1.2% [-1.6, -0.7%] 
Any CVD LSIb 1994-96 5.8% 2011-14 1.1% 0.6% [-0.1, 1.4%] 
Any recent CVD 1994-96 3.1% 2011-14 0.7% 0.5% [-0.1, 1.2%] 
Respiratory  
      Lifetime diagnosed asthma 1994-96 11.2% 2008-10 5.5% 5.7% [4.5, 6.8%] 
Asthma LSIb 1994-96 5.0% 2011-14 0.7% 0.7% [0.0, 1.4%] 
Breathlessness-Grade 2+ 1994-96 19.7% 2008-10 -4.4% -4.8% [-6.1, -3.5%] 
Breathlessness-Grade 3 1994-96 7.8% 2008-10 -1.4% -1.6% [-2.5, -0.8%] 
Recent wheezing/asthma 1994-96 19.5% 2008-10 -1.2% -1.2% [-2.5, 0.1%] 
Wheezing stopping sleep 1994-96 3.6% 2008-10 -0.4% -0.5% [-1.0, 0.1%] 
COPD symptoms 1994-96 6.6% 2008-10 -1.5% -1.6% [-2.3, -0.8%] 
a ‘Adj.’ = adjusted for changing age and sex distribution of the working-age population. b LSI=longstanding illness; see 
Table 1. 
Looking first at high blood pressure, biomarker-measured high blood pressure has halved 
over two decades (similar improvements are found for the biomarkers for total and HDL 
cholesterol). Yet when we look at self-reports (either people reporting this as an LSI, or in 
response to a direct question about having recent diagnosed high blood pressure), we see 
large rises over time. There has been an increasing diagnosis of high blood pressure and 
increasing prescriptions of blood pressure-lowering drugs; these may have helped reduce 
the underlying incidence of high blood pressure while simultaneously raising people’s 
awareness of morbidity. 
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Table 2 further shows declines in several key types of CVD (heart attack, mini-stroke, 
angina), whether measured through people’s reports of the disease itself or their reports of 
its symptoms. Nevertheless, the morbidity declines (8-50%) are often not on the scale of the 
declines in mortality (>50%); this is likely to be because mortality declines are partly driven 
by improved treatment,70 which means each incident CVD case is likely to last longer.71 72 
More surprisingly, the measures of ‘any reported CVD’ show no improvement (with some, 
uncertain signs of rises). Looking at its sub-components (Web Appendix 6), this seems to be 
due to possible increases in diagnosed irregular heart rhythm and other heart trouble. 
Finally, Table 2 shows that symptoms-based measures of respiratory morbidity have 
improved, particularly COPD symptoms (regular cough & phlegm) and breathlessness (at 
both levels), and more uncertainly for recent wheezing/asthma and wheezing stopping sleep. 
Again, though, diagnosis-related measures of asthma – reported diagnoses, or self-reports of 
having asthma as a longstanding illness – have risen, even while underlying symptomatology 
is improving.  
Overall, Table 2 illustrates how changes over time in morbidity do not necessarily follow 
changes in mortality. There are definite improvements in CVD risk factors and respiratory 
symptomatology on the scale of improvements in mortality. But the prevalence of self-
reported CVD conditions such as heart attacks have only declined by a smaller amount, and 
recent doctor-diagnosed hypertension, any CVD, and asthma diagnoses have either stayed 
stable or risen. 
Conditions with claims of increasing prevalence 
The previous section focussed on conditions where there may be an a priori expectation 
that morbidity has improved (given declining mortality); in this section, we focus on three 
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areas where there have been widespread claims of increasing prevalence – obesity, diabetes, 
and mental health.  
Looking at Table 3, we do indeed confirm a large rise in obesity in HSE (an 8.0-9.7% rise 
from an obesity prevalence of 16.9% in 1994-96). The rise in high waist-hip ratios – 
sometimes suggested to be a better measure of potential morbidity 73 – is even larger. This 
has come alongside little change in the prevalence of being underweight over this period.  





Change from start to end period 











Underweight/Obesity       
BMI-Underweight 1994-96 1.0% 2011-14 -0.1% -0.1% [-0.3, 0.1%] 
BMI-Obese 1994-96 16.9% 2011-14 9.3% 8.9% [8.0, 9.7%] 
High waist-hip ratio 1994-96 9.5% 2011-14 14.8% 14.1% [13.0, 15.2%] 
Diabetes       
Recent diabetes 1994-96 1.2% 2011-14 2.4% 2.2% [1.9, 2.6%] 
Diabetes LSIb 1994-96 1.5% 2011-14 2.3% 2.1% [1.5, 2.6%] 
Glycated haemoglobin 2001-03 2.7% 2011-14 2.1% 2.1% [1.4, 2.7%] 
Mental health       
Mental health LSIb 1994-96 2.1% 2011-14 2.5% 2.4% [1.8, 3.0%] 
Psychological distressc 1994-96 17.1% 2011-14 -1.3% -1.3% [-2.4, -0.3%] 
Anx./depression-moderated 1994-96 21.9% 2011-14 0.3% 0.1% [-1.1, 1.3%] 
Anx./depression-extremelyd 1994-96 1.8% 2011-14 1.0% 0.9% [0.5, 1.3%] 
a ‘Adj.’ = adjusted for changing age and sex distribution of the working-age population. b LSI=longstanding illness; see 
Table 1. c GHQ; see Web Appendix 5.  d ‘Anx./depression’= Feeling of anxiety/depression today – see Table 1. 
Table 3 also confirms a large rise in diabetes. This can be seen whether diabetes is measured 
through people reporting diabetes as an LSI, a specific question about people currently 
taking medication for diabetes, or via a diabetes biomarker (glycated haemoglobin). It is 
worth noting that this clear rise in diabetes has occurred despite a decline in the age 0-64 
death rate from diabetes, by more than one-third 1994-2013 (Web Appendix 1) – indeed, 
rising prevalence is because of falling mortality 74 – again demonstrating the difference 
between changes in mortality and morbidity. 
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Trends in mental health are more contentious in the wider literature (see Web Appendix 
8), and the measures in HSE are not as strong as the more occasional Adult Psychiatric 
Morbidity Surveys.75 Nevertheless, HSE offers a unique annual perspective on self-reported 
mental health. As we might expect from increasing treatment/diagnosis, we see a doubling in 
people reporting a mental health LSI. However, the symptoms-based measures show a more 
mixed picture:  
 Neither of the measures that capture more moderate mental ill-health show rising 
ill-health (these are psychological distress symptoms and people reporting a feeling of 
anxiety/depression today, both with a relatively common prevalence of 15-25%). If 
we break this down by year (see Web Appendix 7), we can see moderate mental ill-
health symptoms fell between the mid-1990s and the mid-2000s, before rising in 
2009. 
 In contrast, the single measure capturing a feeling of extreme anxiety/depression 
today does show rising morbidity. To see if there were similar signs of rising mental 
ill-health at extremes in our other measure (psychological distress), we looked at a 
much higher GHQ threshold of 10 negative responses out of 12 questions 
(compared to the conventional threshold of 4). Unlike the conventional GHQ 
measure, this also showed an increase over time (95% CI of a 0.4 to 1.4% rise; see 
Web Appendix 6). While the GHQ is not designed to capture severe psychological 
distress in this way, others have similarly looked at moderate and extreme 
psychological distress using GHQ – and indeed, have found that rises in distress over 
time 1991-2008 are concentrated in the more extreme measure.76 
Overall, while labelling of mental health conditions has undoubtedly risen, trends in mental 
health symptoms vary across measures. If we interpret higher GHQ thresholds as indicating 
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more serious psychological distress, then we can see a consistent picture: moderate mental 
ill-health symptoms fell from the mid-1990s to the mid-2000s before rising around the time 
of the 2008 economic crisis (as we would expect77), whereas more extreme mental ill-health 
has more consistently risen.  
Activity limitations, musculoskeletal and pain 
Pain/musculoskeletal conditions are a major component of working-age morbidity, yet very 
few previous studies show changes over time in symptomatology, and even those that 
exist78 sometimes have debatable comparability.79  Table 4 shows a fall in some – but not all 
– HSE measures focussed on pain and musculoskeletal morbidity. Arthritis as a longstanding 
illness (LSI) has declined (the precision of the estimates is greater when looking at 2008-10 
rather than 2011-14, and shows a decline of 0.3-1.2%). There are some (similarly uncertain) 
signs that other musculoskeletal LSIs have also fallen, and noticeably fewer people say that 
they have any pain/discomfort today, although there has been no change in people saying 
they have extreme pain/discomfort. The echoes a previous study that found different trends 
in low back pain of different levels of severity.80 
Similarly, there has been a rise in all four activity limitations measures in HSE – although the 
increases are sometimes uncertain, and are smaller after adjusting for changes in age/sex 
structure. Moreover, the timing of the rises differ between the measures: the trend in 
limitations lasting at least a year shows a rise 1994-6 to 2001-3, but the two measures of 
‘limitations today’ do not, instead showing a possible slight rise in the more recent period 
(see Web Appendix 7; this difference remains if we focus on the sub-components of year-
long limitations that more closely match to the ‘limitations today’ questions, see Web 
Appendix 6). Still, the measures can collectively be seen as offering some, albeit relatively 
weak, evidence for an increase in activity limitations.  
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Table 4: Changes over time in activity limitations,  




Change from start to end period 
  Period 
 







Activity limitations       
Problems walking about  1994-96 11.5% 2011-14 1.0% 0.4% [-0.6, 1.3%] 
Any locomotor limitation 1994-96 6.8% 2001-03 1.1% 0.9% [0.1, 1.7%] 
Probs. washing/dressing  1994-96 3.4% 2011-14 0.6% 0.3% [-0.2, 0.9%] 
Any self-care limitation 1994-96 3.9% 2001-03 0.8% 0.7% [0.1, 1.3%] 
Musculoskeletal/pain       
Pain-any 1994-96 32.0% 2011-14 -2.2% -3.3% [-4.6, -2.0%] 
Pain-extreme 1994-96 3.0% 2011-14 0.4% 0.2% [-0.3, 0.7%] 
Arthritis LSIb 1994-96 5.3% 2011-14 -0.3% -0.7% [-1.4, 0.0%] 
Other musculoskeletal LSIb 1994-96 9.7% 2011-14 -0.5% -0.8% [-1.7, 0.1%] 
a ‘Adj.’ = adjusted for changing age and sex distribution of the working-age population. b   LSI=longstanding illness; see Table 
1. 
Other measures 
Changes over time in other measures are shown in Table 5 below. This includes four 
biomarkers that are more difficult to compare directly to self-reports: 
- Changes over time are available for two biomarkers of inflammation (C-reactive 
protein (‘CRP’) and fibrinogen). These are associated with a number of conditions 
including heart disease, diabetes, cancer 81 and – in the case of CRP – even 
depression.82 Table 5 shows that both biomarkers have rising morbidity from 1997-
2000 to 2008-10 (although for CRP, the confidence interval is wide and there is a 
non-negligible possibility that the change is negative).  
- The two other biomarkers available in HSE are clearly focussed on anaemia and iron 
deficiency. Table 5 shows that both of these have declined, with particularly clear 








Change from start to end period 
  Period 
 







Other biomarkers       
Raised C-reactive protein 1997-2000 21.4% 2008-10 2.1% 1.9% [-0.7, 4.5%] 
Raised fibrinogen 1997-2000 2.3% 2008-10 1.6% 1.5% [0.3, 2.6%] 
Anaemia 1994-96 6.7% 2008-10 -1.4% -1.4% [-2.7, -0.1%] 
Iron deficiency 1994-96 39.9% 2008-10 -12.9% -12.5% [-14.8, -10.2%] 
Sensory & 
communication       
LSI Eye or Earb 1994-96 2.8% 2011-14 -0.9% -1.0% [-1.5, -0.6%] 
Hearing limitation 1994-96 4.3% 2001-03 -1.5% -1.6% [-2.1, -1.0%] 
Seeing limitation 1994-96 1.4% 2001-03 -0.2% -0.2% [-0.6, 0.1%] 
Communicating limitation 1994-96 1.0% 2001-03 0.1% 0.1% [-0.2, 0.4%] 
a ‘Adj.’ = adjusted for changing age and sex distribution of the working-age population. b LSI=longstanding illness; see Table 
1. 
Table 5 also shows changes over time in sensory and communication-related morbidity. This 
shows a fall in eye/ear conditions (1994-6 to 2011-14) as well as hearing limitations in the 
earlier period (1994-6 to 2001-03), but no change in people having difficulty communicating 
with others.  
DISCUSSION 
Despite considerable evidence on morbidity trends among older people, there are few 
published studies on changes in morbidity among the working-age population, particularly 
outside the USA. In this paper, we have analysed changes over time in working-age 
morbidity in England 1994-2014 using a high-quality repeated cross-sectional study. We see 
improvements in cardiovascular morbidity, respiratory morbidity and anaemia, but 
deteriorating obesity, diabetes, some biomarkers (fibrinogen and possibly also CRP) and 
feelings of extreme anxiety/depression. We see little systematic change over time in more 
common mental ill-health or musculoskeletal conditions, pain/mobility, and self-care 
limitations. Symptomatology and chronic disease diagnoses also often go in different 
directions – chronic disease diagnoses have sometimes stayed stable or even risen at the 
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same time that underlying symptomatology has declined (such as for mental health 
conditions, asthma, hypertension, and CVD as a whole), mirroring findings at older ages.3 
Our analysis has several strengths. We include every morbidity measure for which 
consistent changes can be constructed, including chronic disease, functioning and 
symptomatology, and biomarkers. We use a single survey series collected by a single survey 
organisation; exclude under-25s for whom comparability of survey coverage is unlikely; and 
construct new non-response weights. Nevertheless, we must note three limitations. Firstly, 
response rates for each stage of the HSE have declined over time (see Web Appendix 3), 
and while we create new non-response weights covering the entire period, it is still possible 
that socioeconomically disadvantaged people (within any age-sex-region group) have 
become less likely to respond – and as they tend to be in worse health, this could mask 
deteriorating morbidity. Secondly, even if non-response biases have not changed, it is 
possible that people respond differently over time even to identical questions. Third, there 
are several dimensions of morbidity for which there is little comparable data in HSE. This 
includes several areas in which morbidity among the working-age population seems to be 
rising, including inter alia cognitive complaints,83 allergic disorders,84 and liver cirrhosis (see 
Web Appendix 1), as well as some areas in which morbidity seems likely to have fallen, such 
as chronic kidney disease.85 
It is clear that there are different trends in different dimensions of morbidity – but for 
policymakers, this leaves the question of whether working-age morbidity as a whole is 
unchanged (H2), getting better (H1) or getting worse (H3), to the extent that it makes 
sense to place health on a unidimensional scale. While we cannot create a single morbidity 
index here, Web Appendix 9 shows the association of each measure with bad general self-
rated health (net of age, gender and education). This shows little systematic trend for falling 
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morbidity to be seen in the measures that predict health the most (indeed, the evidence 
weakly points in the other direction, towards rising morbidity). This provides greater 
support for H2 than H1 or H3, mirroring evidence from the Global Burden of Disease study 
(see Web Appendix 9).   
In conclusion, despite considerable falls in working-age mortality and gains in life expectancy 
– and the ensuing expectations of social security policymakers for improving morbidity – 
there is no evidence of systematic improvement in overall working-age morbidity in England 
from 1994 to 2014. However, two pieces of further research could strengthen this evidence 
base. Firstly, the ideal measures for analysing changes in morbidity are functional limitations 
measures, which are included in the HSE from 1996. However, these were last asked to the 
working-age population in 2001, and it is a priority to repeat these measures in future years 
of HSE. Secondly, there is a surprising paucity of studies looking at the changing morbidity of 
the working-age population outside the US. Given their importance in public debate – 
particularly in discussions of retirement ages and disability benefits – we hope that other 
authors will repeat and extend our analyses here, including disaggregating these changes 
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